GA4 (398745346)

The 10th Angiology Congress 02|Focus on innovation and transformation: the 10th Angiology Congress of Integrated Traditional Chinese and Western Medicine was successfully held in Xi’an

The 10th Angiology Congress 02|Focus on innovation and transformation: the 10th Angiology Congress of Integrated Traditional Chinese and Western Medicine was successfully held in Xi’an


Academicians of the Chinese Academy of Engineering made academic sharing, domestic and foreign medical experts exchanged achievements and experiences, and tens of thousands of medical experts watched online… On April 16, the 10th Angiology Conference of Integrated Traditional Chinese and Western Medicine was successfully held in the ancient city of Xi’an.

▲Conference site

Wu Yiling, an academician of the Chinese Academy of Engineering, served as the honorary chairman of the conference, and Jia Zhenhua, chairman of the Vascular-Choroid Disease Professional Committee, served as the chairman of the conference. Professors Zhang Yun, Chen Xiangmei, and Wu Yiling, academicians of the Chinese Academy of Engineering, and Professor Eric D Peterson of the University of Texas Southwestern Medical Center, and other authoritative experts in traditional Chinese and western medicine at home and abroad gathered at the conference to focus on the original major theory of traditional Chinese medicine—the guidance of the vein theory In-depth academic exchanges on the latest progress and scientific research results in the prevention and treatment of vascular diseases.

The event was held in the form of “online + online”. In addition to the main venue in Xi’an, 1,784 video sub-venues were set up in 28 provinces in China, and tens of thousands of medical experts watched the conference online.

  General AssemblyOpening the curtain, Chinese medicine has made a major breakthrough in the prevention and treatment of microvascular diseases

Jia Zhenhua, chairman of the conference, delivered a welcome speech. He said that Academician Wu Yiling presided over two consecutive national “973 Program” projects, and for the first time systematically constructed the theory of veins in traditional Chinese medicine, forming an original theory to guide the prevention and treatment of vascular diseases. The project research has broken through the international bottleneck problem in the prevention and treatment of a single disease in the cardiovascular event chain, and achieved a major breakthrough in systematic intervention, which has been highly praised by the medical circles at home and abroad.

▲Jia Zhenhua, Chairman of the Professional Committee of Vascular-choroidal Diseases

Liu Feng, director of the Shaanxi Administration of Traditional Chinese Medicine, said in his speech that under the leadership of Academician Wu Yiling, the cause of traditional Chinese medicine has achieved great innovative results. The new mode of academic innovation and transformation of traditional Chinese medicine combines traditional Chinese medicine theoretical innovation with modern science and technology to produce major original achievements.

▲Liu Feng, Director of Shaanxi Administration of Traditional Chinese Medicine

In his speech, Sun Zhenlin, President of Shaanxi University of Traditional Chinese Medicine, introduced the achievements of Shaanxi University of Traditional Chinese Medicine under the guidance of the national guidelines and policies on the cause of traditional Chinese medicine. He said that in the future, the school will actively participate in various academic activities of Academician Wu Yiling’s team, reserve and train professional lecturers of collateral diseases, strengthen the construction of excellent courses of collateral diseases, set up collateral disease courses for colleges and universities across the country and strengthen the training of collateral diseases talents , to explore a sustainable development path.

▲Sun Zhenlin, President of Shaanxi University of Traditional Chinese Medicine

Chen Xiangmei, president of the China Association of Integrative Medicine and academician of the Chinese Academy of Engineering, said that the research on “Construction of the Theory of Traditional Chinese Medicine and Its Guide to the Prevention and Treatment of Microvascular Diseases” completed by the team of Academician Wu Yiling used evidence-based medical evidence to confirm the efficacy of traditional Chinese medicine in treating chronic diseases. Modern scientific methods are used to explain why it is effective, providing an integrated traditional Chinese and Western medicine solution for the prevention and treatment of chronic diseases.

▲Chen Xiangmei, President of China Association of Integrative Medicine and Academician of Chinese Academy of Engineering

  Keynote speech, discussing cutting-edge thinking and latest research on vascular diseases

In the keynote report, experts and scholars from home and abroad conducted in-depth sharing on the prevention and treatment strategies of collateral disease theory in the field of vascular diseases, as well as the cutting-edge thinking and latest research on vascular diseases.

▲The first line from left to right is Wu Yiling and Zhang Yun, and the second line from left to right is Jia Zhenhua and Eric Peterson

In the first round of keynote speeches, academician Wu Yiling gave the title of “Construction of TCM Meridian Theory and Its Guidance for Prevention and Treatment of Microvascular Diseases”, Zhang Yun, academician of the Chinese Academy of Engineering, gave the title of “New Mechanism of Tongxinluo Anti-Atherosclerosis”, and Jia Zhenhua gave the title of “Tongxinluo Anti-Atherosclerosis”. Collateral Theory, Yingwei Theory Guidance on Cardiovascular Event Chain System Intervention Research”, and Eric Peterson of the University of Texas Southwestern Medical Center, USA, made an academic sharing on the topic of “The Importance of Randomized Trials in Medicine”, expounding the theory of collateral disease cutting-edge research results.

▲The first line from left to right is Yang Yuejin and Huang Congxin, and the second line from left to right is Li Xinli, Zhao Jiajun, Qu Qiumin

In the second round of keynote speeches, Professor Yang Yuejin from Fuwai Hospital of Chinese Academy of Medical Sciences, Professor Huang Congxin from Wuhan University People’s Hospital, Professor Li Xinli from the First Affiliated Hospital of Nanjing Medical University, Professor Zhao Jiajun from Shandong Provincial Hospital, and Professor Qu Qiumin from the First Affiliated Hospital of Xi’an Jiaotong University They respectively brought “Tongxinluo Prevention and Treatment of AMI Myocardial No-reflow/Reperfusion Injury-Research and Clinical Breakthrough”, “Arrhythmia Mechanism and Drug Intervention for Tongluo Medicine”, “Status and Evaluation of Tongxinluo Drugs in the Treatment of Heart Failure”, “China Interpretation of Type 2 Diabetes Guideline Changes” and “Meridian Dredging Intervention Strategies for Neurological Impairment in Cerebrovascular Diseases” systematically expounded the positive effects of collateral dredging drugs in various fields.

According to reports, Tongxinluo Capsules, Shensong Yangxin Capsules, and Qili Qiangxin Capsules, which are Chinese patent medicines for treating cardiovascular diseases, have made major breakthroughs in the treatment of microvascular diseases, adding a powerful protective “barrier” to people’s cardiovascular health .

  four bigForum, focusing on the status quo and coping strategies of vascular diseases

In the afternoon of the same day, the conference also held cardiovascular disease forums, cerebrovascular disease forums, diabetes forums, and chronic disease management forums.

▲ Cardiovascular disease forum

Focusing on the progress in the treatment of coronary heart disease, arrhythmia/heart failure, experts participating in the cardiovascular disease forum focused on the guidance of collateral disease theory and the application of collateral dredging drugs to contribute professional wisdom.

At the cerebrovascular disease forum, the participating experts discussed in depth the application of the choroid theory in the treatment of cerebrovascular diseases around “therapy for dredging collaterals and neurovascular units, secondary prevention of ischemic stroke, and cerebral small vessel disease”.

For the Diabetes Forum, the experts participating in the meeting provided useful references for the prevention, treatment and management of diabetes with the theme of “diabetes high-quality compliance” and “diabetes chronic disease management”.

Leading collateral diseases, empowered by digital intelligence, at the chronic disease management forum, participating experts focused on “Chinese Tongluo Health Preservation Eight-Character Classic to Guide Chronic Disease Health Management”, “The Impact of Medical Insurance Policy on the Retail Market”, “2022 Chronic Disease Retail Market Situation and In 2023, the industry pre-judged “how to implement chronic disease services in social pharmacies” and other topics, and conducted in-depth discussions to exchange insights for chronic disease management and chronic disease market development.

The system of the vein theory is built on the basis of following the development laws of traditional Chinese medicine, inheriting the essence, keeping the integrity and innovating, promoting the mutual complementarity and coordinated development of traditional Chinese medicine and Western medicine, and becoming a model for the modernization of traditional Chinese medicine. The convening of this conference provides a good platform for strengthening academic exchanges and improving clinical thinking and scientific research capabilities.



Source link